A new report says that the fight against HIV AIDS, tuberculosis and malaria will cost some $87 billion (67 billion euros) between 2014-16.
The Global Fund to fight AIDS, Tuberculosis and Malaria said it estimated $87 billion was needed to "provide essential services for effective treatment ... to vulnerable populations."
Advertisement
The battle against AIDS alone will cost some $58 billion in 2014-16, it said, with tuberculosis needing $15 billion and malaria $14 billion.
"Today, we have a historic chance to control completely these diseases. If we do not take it, the long term cost will be colossal," Global Fund head Mark Dybul said.
If all the funding is provided, it will be possible to treat some 17 million tuberculosis patients and to prevent millions of new AIDS and malaria cases each year, the group said.
Source: AFP
If all the funding is provided, it will be possible to treat some 17 million tuberculosis patients and to prevent millions of new AIDS and malaria cases each year, the group said.
Source: AFP
AIDS and Pregnancy
The Acquired immune deficiency syndrome is brought about by the deadly human immunodeficiency virus. In the USA alone an estimate of 120,000 - 160,000 women are HIV- infected.
Advertisement
 AIDS/HIV - Clinical FeaturesEncyclopedia section of medindia gives general info about HIV Clinical Features | Advertisement
|
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV
Advertisement
Recommended Readings
Latest AIDS/HIV News
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
